|
Caryoynencin |
0 |
0.56 |
0.49 |
0.75 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C#CC#CC#CC#C/C=C/C=C/C(O)CCCCC(=O)O |
view |
Caryoynencin |
|
|
Borrelidin |
13 |
0.51 |
0.43 |
0.69 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1C[C@H](C)[C@@H](O)CC(=O)O[C@H]([C@@H]2CCC[C@H]2C(=O)O)C/C=C\C=C(\C#N)[C@H](O)[C@@H](C)C[C@H](C)C1 |
view |
Borrelidin |
|
|
9-methylstreptimidone |
35 |
0.47 |
0.46 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C\C(C)=C\[C@H](C)C(=O)C[C@H](O)CC1CC(=O)NC(=O)C1 |
view |
9-methylstreptimidone |
|
|
gibberellin A4 |
1 |
0.55 |
0.43 |
0.77 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=C1C[C@]23C[C@H]1CC[C@H]2[C@@]12CC[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O |
view |
gibberellin A4 |
|
|
gibberellin A7 |
2 |
0.54 |
0.45 |
0.75 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=C1C[C@]23C[C@H]1CC[C@H]2[C@@]12C=C[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O |
view |
gibberellin A7 |
|
|
gibberellin A3 |
3 |
0.54 |
0.43 |
0.75 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=C1C[C@]23C[C@@]1(O)CC[C@H]2[C@@]12C=C[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O |
view |
gibberellin A3 |
|
|
herboxidiene |
4 |
0.54 |
0.49 |
0.72 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@@H]([C@@H](C)O)[C@@H](C)[C@H]1O[C@]1(C)C[C@H](C)/C=C/C=C(\C)[C@H]1O[C@@H](CC(=O)O)CC[C@@H]1C |
view |
herboxidiene |
|
|
phytocassane |
5 |
0.53 |
0.45 |
0.72 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=CC1=CC(=O)[C@H]2[C@@H](CC[C@H]3C(C)(C)C(=O)[C@@H](O)C[C@]23C)[C@H]1C |
view |
phytocassane |
|
|
Lactimidomycin |
6 |
0.53 |
0.47 |
0.71 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C(=C\[C@H](C)C(=O)C[C@H](O)CC1CC(=O)NC(=O)C1)[C@@H]1OC(=O)/C=C\CC/C=C\C=C/[C@@H]1C |
view |
Lactimidomycin |
|
|
ebelactone |
7 |
0.53 |
0.47 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)/C=C(\C)C[C@H](C)[C@@H]1OC(=O)[C@H]1C |
view |
ebelactone |
|
|
equisetin |
8 |
0.52 |
0.44 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/[C@@H]1C=C[C@@H]2C[C@H](C)CC[C@H]2[C@]1(C)/C(O)=C1/C(=O)[C@H](CO)N(C)C1=O |
view |
equisetin |
|
|
eicosapentaenoic acid |
9 |
0.52 |
0.47 |
0.68 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O |
view |
eicosapentaenoic acid |
|
|
13-epi-Dorrigocin A |
10 |
0.52 |
0.5 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
13-epi-Dorrigocin A |
|
|
Dorrigocin A |
11 |
0.52 |
0.5 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)/C=C(\C)[C@H](O)[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin A |
|
|
lycosantalonol |
12 |
0.51 |
0.43 |
0.7 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)=CCCC(C)(O)C(=O)CC[C@]1(C)C2CC3C(C2)C31C |
view |
lycosantalonol |
|
|
Wortmanamide |
36 |
0.47 |
0.49 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H](O)C/C=C/CCCCCCCC/C=C/C(=O)NCCCCC(=O)O |
view |
Wortmanamide |
|
|
reveromycin |
14 |
0.51 |
0.47 |
0.67 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCC[C@@]1(OC(=O)CCC(=O)O)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)C(C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O |
view |
reveromycin |
|
|
Abyssomicin C |
15 |
0.51 |
0.47 |
0.66 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C[C@@H]1C/C=C\[C@@H]2[C@@H](O)[C@@H]3OC4=C(C(=O)O[C@]42C[C@H]3C)C(=O)[C@H](C)C1 |
view |
Abyssomicin C |
|
|
Aurafuron A |
16 |
0.51 |
0.51 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC1=C(CC(O)/C=C\C=C\C(C)C(O)/C(C)=C/CC(C)C)OC(C)(O)C1=O |
view |
Aurafuron A |
|
|
vicenistatin |
17 |
0.51 |
0.44 |
0.56 |
0.5 |
Glyco:1/3 |
MIBiG |
Source |
CN[C@H]1[C@@H](O)C[C@H](O[C@H]2C/C=C(/C)C/C(C)=C\C=C/CC[C@H](C)CNC(=O)/C=C\C=C/[C@@H]2C)O[C@@H]1C |
view |
vicenistatin |
|
|
fusaridione A |
18 |
0.5 |
0.44 |
0.68 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/[C@@H]1C=C[C@@H]2C[C@H](C)CC[C@H]2[C@]1(C)C(=O)C1=C(O)N(C)[C@@H](CO)C1=O |
view |
fusaridione A |
|
|
heronamide D |
19 |
0.5 |
0.44 |
0.66 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/CC1C[C@H](O)C2C3/C(C)=C\C4C=C[C@@H](O)[C@@H](O)C4/C(C)=C\C=C/C3C(=O)N12 |
view |
heronamide D |
|
|
ambruticin |
20 |
0.5 |
0.46 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H]1O[C@@H](/C(C)=C/[C@H](C)/C=C/[C@@H]2[C@@H](/C=C/[C@@H]3O[C@H](CC(=O)O)C[C@H](O)[C@H]3O)[C@@H]2C)CC=C1C |
view |
ambruticin |
|
|
E-837 |
21 |
0.5 |
0.47 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C(\C)C(O)C(C)/C=C/C=C(\C)CCC(O)CC1=C(C)C(=O)C(C)(O)O1 |
view |
E-837 |
|
|
Dorrigocin B |
22 |
0.5 |
0.48 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@@H](/C=C/CC/C=C/C(=O)O)[C@@H](O)[C@H](C)[C@@H](O)/C(C)=C/[C@H](C)C(=O)CCCC1CC(=O)NC(=O)C1 |
view |
Dorrigocin B |
|
|
E-975 |
23 |
0.5 |
0.5 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-975 |
|
|
Kalimantacin A |
24 |
0.5 |
0.5 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=C(CCC=CC=CCC(C)CC(=O)CC(O)CNC(=O)C(C)C(C)OC(N)=O)CC(C)CC(C)=CC(=O)O |
view |
Kalimantacin A |
|
|
isobongkrekic acid |
25 |
0.5 |
0.56 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H](C/C=C\C=C\CC/C=C/C[C@H](C)/C=C/C(=C/C(=O)O)CC(=O)O)/C(C)=C\C=C(C)C |
view |
isobongkrekic acid |
|
|
phoslactomycin B |
26 |
0.49 |
0.43 |
0.66 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H]1C=CC(=O)O[C@H]1/C=C/[C@](O)(CCN)[C@@H](C[C@@H](O)/C=C\C=C/C1CCCCC1)OP(=O)(O)O |
view |
phoslactomycin B |
|
|
Cinnabaramide |
27 |
0.49 |
0.44 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCCCC[C@H]1C(=O)N[C@@]2([C@@H](O)[C@@H]3C=CCCC3)C(=O)O[C@@]12C |
view |
Cinnabaramide |
|
|
heronamide A |
28 |
0.49 |
0.44 |
0.65 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@H](O)C2[C@@H]3/C(C)=C\[C@@H]4C=C[C@H](O)[C@H](O)[C@H]4/C(C)=C\C=C/[C@H]3C(=O)N21 |
view |
heronamide A |
|
|
metatricycloene |
29 |
0.49 |
0.47 |
0.63 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
NC(=O)/C=C/C=C/C1C=CC2C=CC3OC(/C=C/C=C/C=C/C(=O)O)C1C23 |
view |
metatricycloene |
|
|
E-492 |
30 |
0.49 |
0.51 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C(\C)C(O)C(C)/C=C/C=C/CCC(O)CC1=C(C)C(=O)C(O)(C(C)O)O1 |
view |
E-492 |
|
|
galbonolide A |
31 |
0.48 |
0.42 |
0.64 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C=C1/C=C(/C)[C@H](CC)OC(=O)[C@H](C)C(=O)C(O)(CO)C/C(OC)=C\[C@@H](C)C1 |
view |
galbonolide A |
|
|
bongkrekic acid |
32 |
0.48 |
0.54 |
0.56 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
COC(C/C=C\C=C\CC/C=C/CC(C)/C=C/C(=C\C(=O)O)CC(=O)O)/C(C)=C\C=C(/C)C(=O)O |
view |
bongkrekic acid |
|
|
Thailanstatin A |
33 |
0.47 |
0.42 |
0.62 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(=O)O[C@@H](C)/C=C\C(=O)N[C@@H]1C[C@H](C)[C@H](C/C=C(C)/C=C/[C@H]2O[C@H](CC(=O)O)C[C@@]3(CO3)[C@@H]2O)O[C@@H]1C |
view |
Thailanstatin A |
|
|
xenolozoyenone |
34 |
0.47 |
0.46 |
0.59 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCCCC/C=C/C=C/C=C/C(O)=C1\C(=O)CN(O)C1=O |
view |
xenolozoyenone |
|
|
alpha-lipomycin |
37 |
0.47 |
0.44 |
0.48 |
0.5 |
Glyco:1/3 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
JBIR-100 |
38 |
0.46 |
0.42 |
0.6 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C1=C/C(C)C(O)C(C)C/C(C)=C\C=C/CC(C(C)C(O)C(C)C2(O)CC(OC(=O)/C=C/C(=O)O)C(C)C(C(C)C)O2)OC(=O)\C(C)=C/1 |
view |
JBIR-100 |
|
|
heronamide E |
39 |
0.45 |
0.43 |
0.57 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
C/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@H]3C=C[C@@H](O)[C@@H](O)[C@@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide E |
|
|
coronatine |
40 |
0.44 |
0.45 |
0.55 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H]1C[C@@]1(NC(=O)C1=C[C@H](CC)C[C@@H]2C(=O)CC[C@H]12)C(=O)O |
view |
coronatine |
|
|
fumagillin |
41 |
0.41 |
0.45 |
0.48 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2 |
view |
fumagillin |
|
|
AF-toxin |
42 |
0.39 |
0.49 |
0.41 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCC(C)C(OC(=O)C(O)C(C)(C)O)C(=O)OC(/C=C/C=C/C=C/C(=O)O)C1(C)CO1 |
view |
AF-toxin |
|
|
botcinic acid |
43 |
0.38 |
0.45 |
0.43 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CCCC[C@H](O)/C=C/C(=O)O[C@H]1[C@H](C)O[C@](C)([C@@H](O)[C@@H](C)C(=O)O)[C@@H](O)[C@@H]1C |
view |
botcinic acid |
|
|
fortimicin |
44 |
0.36 |
0.44 |
0.27 |
0.5 |
Glyco:1/3 |
MIBiG |
Source |
CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H](C(C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN.O=S(=O)(O)O.O=S(=O)(O)O |
view |
fortimicin |
|
|
valclavam |
45 |
0.34 |
0.47 |
0.32 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)C(N)C(=O)NC(C(=O)O)C(O)CC1CN2C(=O)CC2O1 |
view |
valclavam |
|
|
belactosin A |
46 |
0.33 |
0.44 |
0.33 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H](C)[C@@H]1C(=O)O[C@H]1C(=O)N[C@H]1C[C@H]1C[C@H](NC(=O)[C@H](C)N)C(=O)O |
view |
belactosin A |
|
|
isopenicillin N |
47 |
0.33 |
0.43 |
0.33 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC1(C)S[C@@H]2[C@H](NC(=O)CCC[C@H](N)C(=O)O)C(=O)N2[C@H]1C(=O)O |
view |
isopenicillin N |
|
|
belactosin C |
48 |
0.32 |
0.43 |
0.32 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC[C@H](C)[C@@H]1C(=O)O[C@H]1C(=O)NCCC[C@H](NC(=O)[C@H](C)N)C(=O)O |
view |
belactosin C |
|
|
yersiniabactin |
49 |
0.28 |
0.44 |
0.23 |
0.0 |
Glyco:0/3 |
MIBiG |
Source |
CC(C)(C1=N[C@@](C)(C(=O)O)CS1)[C@H](O)[C@@H]1CSC([C@H]2CS/C(=C3\C=CC=CC3=O)N2)N1 |
view |
yersiniabactin |
|